• 1
    Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996; 124:65463.
  • 2
    Besson C, Goubar A, Gabarre J et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 98:233944.
  • 3
    Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000; 27:390401.
  • 4
    Haioun C, Lepage E, Gisselbrecht C et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1997; 15:11317.
  • 5
    Diez-Martin JL, Balsalobre P, Re A et al. Comparable survival between HIV positive and HIV negative non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 2009; 113:60114.
  • 6
    Wagner-Johnston ND, Ambinder RF. Blood and marrow transplant for lymphoma patients with HIV/AIDS. Curr Opin Oncol 2008; 20:2015.
  • 7
    Krishnan A. HIV-infected patients. Biol Blood Marrow Transplant 2009; 15:1425.
  • 8
    Gupta V, Tomblyn M, Pedersen TL et al. Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009; 15:86471.
  • 9
    Krown SE, Real FX, Cunningham-Rundles S et al. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 1983; 308:10716.
  • 10
    Oswald GA, Theodossi A, Gazzard BG, Byrom NA, Fisher-Hoch SP. Attempted immune stimulation in the gay compromise syndrome. BMJ (Clin Res Ed) 1982; 285:1082.
  • 11
    Masur H. The acquired immunodeficiency syndrome. Dis Mon 1983; 30:148.
  • 12
    Hassett JM, Zaroulis CG, Greenberg ML, Siegal FP. Bone marrow transplantation in AIDS. N Engl J Med 1983; 309:665.
  • 13
    Davis KC, Hayward A, Ozturk G, Kohler PF. Lymphocyte transfusion in case of acquired immunodeficiency syndrome. Lancet 1983; 1:599600.
  • 14
    Verdonck LF, de Gast GC, Lange JM, Schuurman HJ, Dekker AW, Bast BJ. Syngeneic leukocytes together with suramin failed to improve immunodeficiency in a case of transfusion-associated AIDS after syngeneic bone marrow transplantation. Blood 1988; 71:66671.
  • 15
    Furlini G, Re MC, Bandini G, Albertazzi L, La Placa M. Antibody response to human immunodeficiency virus after infected bone marrow transplant. Eur J Clin Microbiol Infect Dis 1988; 7:6646.
  • 16
    Bardini G, Re MC, Rosti G, Belardinelli AR. HIV infection and bone-marrow transplantation. Lancet 1991; 337:11634.
  • 17
    Thomas E, Storb R, Clift RA et al. Bone-marrow transplantation (first of two parts). N Engl J Med 1975; 292:83243.
  • 18
    Lane HC, Masur H, Longo DL et al. Partial immune reconstitution in a patient with the acquired immunodeficiency syndrome. N Engl J Med 1984; 311:1099103.
  • 19
    Mitsuyasu R, Volberdin P, Groopman J, Champlin R. Bone marrow transplantation from identical twins in the treatment of AIDS and Kaposi's sarcoma. J Cell Biochem 1984; 26:22.
  • 20
    Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science 1976; 192:10168.
  • 21
    Gale RP, Sparkes RS, Golde DW. Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. Science 1978; 201:9378.
  • 22
    Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988; 239:2902.
  • 23
    Fischl MA, Richman DD, Grieco MH et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987; 317:18591.
  • 24
    Holland HK, Saral R, Rossi JJ et al. Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med 1989; 111:97381.
  • 25
    Saral R, Holland HK. Bone marrow transplantation for acquired immune deficiency syndrome. In: FormanSJ, BlumeKG, ThomasED, eds. Bone marrow transplantation. Boston: Blackwell Scientific Publications, 1994:65464.
  • 26
    Lane HC, Zunich KM, Wilson W et al. Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection. Ann Intern Med 1990; 113:5129.
  • 27
    Angelucci E, Lucarelli G, Baronciani D et al. Bone marrow transplantation in an HIV positive thalassemic child following therapy with azidothymidine. Haematologica 1990; 75:2857.
  • 28
    Aboulafia DM, Mitsuyasu RT, Miles SA. Syngeneic bone-marrow transplantation and failure to eradicate HIV. Aids 1991; 5:344.
  • 29
    Giri N, Vowels MR, Ziegler JB. Failure of allogeneic bone marrow transplantation to benefit HIV infection. J Paediatr Child Health 1992; 28:3313.
  • 30
    Torlontano G, Di Bartolomeo P, Di Girolamo G et al. AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin. Haematologica 1992; 77:28790.
  • 31
    Palella FJ, Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:85360.
  • 32
    Schlegel P, Beatty P, Halvorsen R, McCune J. Successful allogeneic bone marrow transplant in an HIV-1-positive man with chronic myelogenous leukemia. J Acquir Immune Defic Syndr 2000; 24:28990.
  • 33
    Tomonari A, Takahashi S, Shimohakamada Y et al. Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemia. Bone Marrow Transplant 2005; 36:2612.
  • 34
    Bryant A, Milliken S. Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma. Biol Blood Marrow Transplant 2008; 14:6012.
  • 35
    Kang EM, de Witte M, Malech H et al. Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood 2002; 99:698701.
  • 36
    Sora F, Antinori A, Piccirillo N et al. Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia. Exp Hematol 2002; 30:27984.
  • 37
    Wolf T, Rickerts V, Staszewski S et al. First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemia. Haematologica 2007; 92:e5658.
  • 38
    Polizzotto MN, Shortt J, Cole-Sinclair MF, Opat SS, Spencer A, Avery S. Allogeneic peripheral blood stem cell transplantation for hematological malignancies in patients with HIV. ASH Annu Meet Abstr 2007; 110:4941.
  • 39
    Avettand-Fenoel V, Mahlaoui N, Chaix ML et al. Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART. Aids 2007; 21:7767.
  • 40
    Jenq RR, van den Brink MR. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Cancer 2010; 10:21321.
  • 41
    Barry M, Mulcahy F, Merry C, Gibbons S, Back D. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clin Pharmacokinet 1999; 36:289304.
  • 42
    Krishnan A, Molina A, Zaia J et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 2005; 105:8748.
  • 43
    Serrano D, Carrion R, Balsalobre P et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 2005; 33:48794.
  • 44
    Mounier N, Katlama C, Costagliola D, Chichmanian RM, Spano JP. Drug interactions between antineoplastic and antiretroviral therapies: implications and management for clinical practice. Crit Rev Oncol Hematol 2008; 72:1020.
  • 45
    Kaczmarski RS, Davison F, Blair E et al. Detection of HIV in haemopoietic progenitors. Br J Haematol 1992; 82:7649.
  • 46
    Stanley SK, Kessler SW, Justement JS et al. CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 1992; 149:68997.
  • 47
    Zhang J, Crumpacker CS. Hematopoietic stem and progenitor cells in HIV/AIDS and immune reconstitution. Cell Res 2010; 20:7457.
  • 48
    Rizzardi GP, Harari A, Capiluppi B et al. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J Clin Invest 2002; 109:6818.
  • 49
    Kamp C, Wolf T, Bravo IG et al. Decreased HIV diversity after allogeneic stem cell transplantation of an HIV-1 infected patient: a case report. Virol J 2010; 7:55.
  • 50
    Woolfrey AE, Malhotra U, Harrington RD et al. Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation. Blood 2008; 112:34847.
  • 51
    Vilmer E, Rhodes-Feuillette A, Rabian C et al. Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation 1987; 44:259.
  • 52
    Morgan RA, Walker R. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. Hum Gene Ther 1996; 7:1281306.
  • 53
    Morgan RA, Walker R, Carter CS et al. Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals. Hum Gene Ther 2005; 16:106574.
  • 54
    Contu L, La Nasa G, Arras M et al. Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. Bone Marrow Transplant 1993; 12:66971.
  • 55
    La Nasa G, Carcassi C, Pizzati A et al. Allogeneic bone marrow transplantation (BMT) combined with zidovudine (AZT), alpha 2 interferon (alpha 2-IFN) and donor HIV-1 specific T-cell clones in an AIDS patient. Int Conf AIDS 1991; 7:77 (abstract no. TH.B.81).
  • 56
    Bex F, Hermans P, Sprecher S et al. Syngeneic adoptive transfer of anti-human immunodeficiency virus (HIV-1)-primed lymphocytes from a vaccinated HIV-seronegative individual to his HIV-1-infected identical twin. Blood 1994; 84:331726.
  • 57
    Strayer DS, Akkina R, Bunnell BA et al. Current status of gene therapy strategies to treat HIV/AIDS. Mol Ther 2005; 11:82342.
  • 58
    Hütter G, Ganepola S. Stem cell based treatment of HIV infection. In: HajbaL, ed. Treatment strategies: AIDS. London: The Cambridge Research Centre, 2010:1921.
  • 59
    DiGiusto DL, Krishnan A, Li L et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2010; 2:36ra43.
  • 60
    Chen TK, Moore TB, Territo M et al. The feasibility of using CCR5D32/D32 hematopoietic stem cell transplants for immune reconstitution in HIV-infected children. Biol Blood Marrow Transplant 2008; 14:Abstract 324.
  • 61
    Gonzalez G, Park S, Chen D, Armitage S, Shpall E, Behringer R. Identification and frequency of CCR5 d32/d32 HIV-resistant cord blood units from Houston area hospitals. HIV Med 2011; ISSN: 1468-1293 [in press].
  • 62
    Holt N, Wang J, Kim K et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28:83947.
  • 63
    Hütter G, Nowak D, Mossner M et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360:6928.
  • 64
    Hütter G, Thiel E. Allogeneic transplantation of CCR5 deficient progenitor cells in a patient with HIV infection – an update after 3 years and the search for patient no. 2. AIDS 2011; 25:2734.
  • 65
    Turner ML, Watson HG, Russell L, Langlands K, Ludlam CA, Parker AC. An HIV positive haemophiliac with acute lymphoblastic leukaemia successfully treated with intensive chemotherapy and syngeneic bone marrow transplantation. Bone Marrow Transplant 1992; 9:3879.
  • 66
    Campbell P, Iland H, Gibson J, Joshua D. Syngeneic stem cell transplantation for HIV-related lymphoma. Br J Haematol 1999; 105:7958.
  • 67
    Shamansky S, Fedotova I, Popkov J, Burya A, Rukavicin O. Allogenic stem cell transplantation in a patient with acute myeloid leukaemia and HIV, hepatitis C infections. Bone Marrow Transplant 2004; 33:S344345 (abstract no. R1215).
  • 68
    Binaghi MA, Lasala MB, Longoni H, Corach D, Kohan A. Peripheral blood stem cell transplantation in a patient with acquired aplastic anemia and HIV infection. ASH Annu Meet Abstr 2006; 108:5368.
  • 69
    Hamnadani M, Baiocchi R, Lin T et al. Feasibility of allogeneic peripheral blood stem cell transplantation (ALLO-SCT) following reduced intensity conditioning (RIC) in HIV+ patients with hematological malignancies. Biol Blood Marrow Transplant 2009; 15 (abstract no. 314).
  • 70
    Polizzotto MN, Skinner M, Cole-Sinclair MF, Opat SS, Spencer A, Avery S. Allo-SCT for hematological malignancies in the setting of HIV. Bone Marrow Transplant 2010; 45:5846.
  • 71
    Gatti G, De Pascalis CR, Toffoli G. Case control study of indinavir pharmacokinetics in patients undergoing chemotherapy for AIDS related neoplasia. 2nd International Workshop on Clinical Pharmacology of HIV Therapy, Noordwijk, the Netherlands; 2001. Abstract no. 1.5.
  • 72
    El-Atrouni WI, Temesgen Z. Darunavir. Drugs Today (Barc) 2007; 43:6719.
  • 73
    Vogel M, Voigt E, Michaelis HC et al. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients. Liver Transpl 2004; 10:93944.
  • 74
    Frassetto LA, Baloum M, Roland ME, Carlson L, Stock P, Benet LZ. Two-year evaluation of the interactions between antiretroviral medication and cyclosporine in HIV+ liver and kidney transplant recipients. 10th Conference on retroviruses and opportunistic infections, Boston, USA; 2003. Abstract no. 540.
  • 75
    Brinkman K, Huysmans F, Burger DM. Pharmacokinetic interaction between saquinavir and cyclosporine. Ann Intern Med 1998; 129:9145.
  • 76
    Sankatsing S, Hoggard P, Back D et al. Mycophenolate mofetil lowers plasma nevirapine concentrations but has no effect on intracellular triphosphate concentrations. 10th Conference on retroviruses and opportunistic infections, Boston, USA; 2003. Abstract no. 539.
  • 77
    Schvarcz R, Rudbeck G, Soderdahl G, Stahle L. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). Transplantation 2000; 69:21945.
  • 78
    Teicher E, Taburet AM, Vincent I et al. Management of drug-to-drug interactions between tacrolimus and HiAART. 12th Conference on retroviruses and opportunistic infections, Boston, USA; 2005. Abstract no. 662.